Prognostic value of serial alactic base excess measurements in patients with sepsis: a retrospective cohort study

Background This study evaluated the prognostic significance of serial alactic base excess (ABE) measurements in patients with sepsis. Methods We conducted a retrospective cohort study including 521 adult patients with sepsis. Arterial blood gas analyses obtained at 0, 6, 12, 24, and 48 h were used to calculate ABE. Patients were classified into three trajectory groups: persistently low ABE (ABE < 0 at all time points), normalizing ABE (initial ABE < 0 with recovery to ≥0 by 48 h), and normal ABE (ABE ≥ 0 at admission). The primary outcome was 28-day mortality. Results Overall 28-day mortality was 35.9%. Non-survivors exhibited more severe metabolic derangement at admission, with higher lactate levels (median 4.22 [2.89–5.31] vs. 3.66 [2.31–4.82] mmol/L) and more negative base excess values (median −6.00 [−8.54 to −3.88] vs. −5.09 [−7.63 to −2.71] mmol/L) (both p < 0.001). Admission ABE was significantly lower in non-survivors and remained consistently reduced throughout the first 48 h (all p < 0.001). Patients with a persistently low ABE trajectory experienced the highest mortality compared with those whose ABE normalized (52.9% vs. 19.8%, p < 0.001). In multivariable Cox regression adjusted for age, sex, baseline eGFR, SOFA score, and APACHE II score, persistently low ABE independently predicted 28-day mortality (adjusted HR 2.539; 95% CI 1.510–4.267; p < 0.001). Furthermore, each 1 mmol/L increase in ΔABE over 48 h was associated with a 25% relative reduction in mortality risk (adjusted HR 0.750; 95% CI 0.633–0.889; p = 0.001). At ICU admission, ABE showed numerically higher discrimination for 28-day mortality than BE (AUC 0.671 vs. 0.639), although this difference did not reach statistical significance ( p = 0.057). Conclusion Serial ABE trajectories provide independent prognostic information in sepsis. Failure to normalize ABE within the first 48 h identifies a high-risk phenotype associated with markedly increased short-term mortality.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-03-13
DOI
https://doi.org/10.3389/fmed.2026.1755874
Primary Topic
Renal function and acid-base balance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic value of serial alactic base excess measurements in patients with sepsis: a retrospective cohort study

MUHAMMET CEMAL KIZILARSLANOĞLU, Dursun Elmas
Frontiers in Medicine
Renal function and acid-base balance
article

Prognostic value of serial alactic base excess measurements in patients with sepsis: a retrospective cohort study

MUHAMMET CEMAL KIZILARSLANOĞLU, Dursun Elmas
article en

Abstract

Background This study evaluated the prognostic significance of serial alactic base excess (ABE) measurements in patients with sepsis. Methods We conducted a retrospective cohort study including 521 adult patients with sepsis. Arterial blood gas analyses obtained at 0, 6, 12, 24, and 48 h were used to calculate ABE. Patients were classified into three trajectory groups: persistently low ABE (ABE < 0 at all time points), normalizing ABE (initial ABE < 0 with recovery to ≥0 by 48 h), and normal ABE (ABE ≥ 0 at admission). The primary outcome was 28-day mortality. Results Overall 28-day mortality was 35.9%. Non-survivors exhibited more severe metabolic derangement at admission, with higher lactate levels (median 4.22 [2.89–5.31] vs. 3.66 [2.31–4.82] mmol/L) and more negative base excess values (median −6.00 [−8.54 to −3.88] vs. −5.09 [−7.63 to −2.71] mmol/L) (both p < 0.001). Admission ABE was significantly lower in non-survivors and remained consistently reduced throughout the first 48 h (all p < 0.001). Patients with a persistently low ABE trajectory experienced the highest mortality compared with those whose ABE normalized (52.9% vs. 19.8%, p < 0.001). In multivariable Cox regression adjusted for age, sex, baseline eGFR, SOFA score, and APACHE II score, persistently low ABE independently predicted 28-day mortality (adjusted HR 2.539; 95% CI 1.510–4.267; p < 0.001). Furthermore, each 1 mmol/L increase in ΔABE over 48 h was associated with a 25% relative reduction in mortality risk (adjusted HR 0.750; 95% CI 0.633–0.889; p = 0.001). At ICU admission, ABE showed numerically higher discrimination for 28-day mortality than BE (AUC 0.671 vs. 0.639), although this difference did not reach statistical significance ( p = 0.057). Conclusion Serial ABE trajectories provide independent prognostic information in sepsis. Failure to normalize ABE within the first 48 h identifies a high-risk phenotype associated with markedly increased short-term mortality.

Frontiers in MedicineVol. 13
University of Health Science (KH), Sağlık Bilimleri Üniversitesi (TR), University of Health Sciences Antigua (AG)
Good health and well-being
Openalex Percentile: Top 32%
Renal function and acid-base balance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.